EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review

Chang Yang, Bing He iD, Hua Zhang, Xueqing Wang, Qiang Zhang, Wenbing Dai iD

Pharmaceutics · 05.01.2023 · 15 (1) · 187

DOI: 10.3390/pharmaceutics15010187 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 05.01.2023. Verfasst von Chang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Phar…. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Beijing Natural Science Foundation, AI + Health Collaborative Innovation Cultivation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies are not only an important class of biotherapeutic drugs, but also are targeting moieties for achieving active targeting drug delivery. Meanwhile, the rapidly increasing application of antibodies and Fc-fusion proteins has inspired the emerging development of downstream processing technologies. Thus, IgG Fc affinity ligands have come into being and have been widely exploited in antibody purification strategies. Given the high binding affinity and specificity to IgGs, binding stability in physiological medium conditions, and favorable toxicity and immunogenicity profiles, Fc affinity ligands are gradually applied to antibody delivery, non-covalent antibody–drug conjugates or antibody-mediated active-targeted drug delivery systems. In this review, we will briefly introduce IgG affinity ligands that are widely used at present and summarize their diverse applications in the field of antibody-involved drug delivery. The challenges and outlook of these systems are also discussed.

Schlagwörter

Stichwörter der Autor:innen

IgG affinity ligandsactive targetingantibody deliveryantibody–drug conjugatesdrug delivery

Autor:innen und Institutionen

  • Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

ORCID-Profile: Bing He, Wenbing Dai

Förderung

  • National Key R&D Program of China
  • Beijing Natural Science Foundation
  • AI + Health Collaborative Innovation Cultivation Project
  • National Natural Science Foundation of China
  • National Key R&D Program of China

Zitieren

APA

Yang, C., He, B., Zhang, H., Wang, X., Zhang, Q., & Dai, W. (2023). IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review. Pharmaceutics, 15(1), 187. https://doi.org/10.3390/pharmaceutics15010187

Vancouver

Yang C, He B, Zhang H, Wang X, Zhang Q, Dai W. IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review. Pharmaceutics. 2023;15(1):187. doi:10.3390/pharmaceutics15010187

BibTeX
@article{Yang2023,
  author = {Yang, Chang and He, Bing and Zhang, Hua and Wang, Xueqing and Zhang, Qiang and Dai, Wenbing},
  title = {IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {187},
  doi = {10.3390/pharmaceutics15010187}
}
Kostenlos starten →